SubHero Banner
Text

Fintepla® (fenfluramine) – New orphan drug approval

June 25, 2020 - The FDA announced the approval of Zogenix’s Fintepla (fenfluramine), for the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older.

Download PDF